CHWY Chewy Inc

Previous close
$26.87
Est. 12 months change
+60.43%
Projected Price
$43.27

Profitability Metrics

Return on Equity (ROE)
57.27%
Return on Assets (ROA)
6.00%
Return on Invested Capital (ROIC)
50.80%
Weighted Average Cost of Capital (WACC)
12.53%
ROIC - WACC
38.26%
Updated : 2026-04-03 19:45 ET

Valuation Metrics

P/E Ratio
51.67
Forward P/E
23.12
PEG Ratio
0.71
Debt Current Ratio
0.88

Growth & Cash Flow

Gross Margin
29.79%
Operating Margin
2.02%
FCF Margin
4.46%
TTM Revenue Growth
0.53%
Projected 12M EPS Growth
123.49%

Price Change

Price % from 50 SMA
1.58%
Price % from 200 SMA
-20.89%
6 Months
-31.54%
1 Year
-20.97%
2 Years
70.49%
Click here to see the list of ETFs containing CHWY as a top holding :Chewy Inc ETFs

Analysis

Company Overview

Chewy operates a leading online pet food, treat, and supplies retailer, with an emphasis on subscription auto-ship services and veterinary telehealth offerings. Sector: Consumer Discretionary.

Overview

Chewy Inc (CHWY) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

Looking at how effectively the company deploy capital, ROIC is 50.80%, WACC is 12.53%, and the economic spread is 38.26%. On balance, the company is earning returns on capital well in excess of what investors and creditors require — the defining characteristic of a high-quality compounding company. Supporting metrics show ROE at 57.27% and ROA at 6.00%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

Valuation

From a pricing standpoint, the company sits at trailing P/E of 51.67, forward P/E of 23.12, PEG of 0.71. A wide spread between trailing and forward P/E implies the market is embedding substantial earnings improvement into current prices. Growth-adjusted valuation is compelling at this PEG level — the multiple appears reasonable given the expected earnings trajectory. A current ratio reading of 0.88 suggests the company carries less short-term financial cushion than the broader market average. In total, the multiple and liquidity readings describe a company where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 29.79%, operating margin at 2.02%, and free cash flow margin at 4.46%. The company's gross margins reflect businesses operating in environments with meaningful cost pressure at the production layer. The company's operating margins are minimal, reflecting a company where overhead costs are not yet well absorbed by revenues. At this level, free cash flow is not a meaningful source of financial flexibility for the company's underlying the company. This margin configuration supports a cautious interpretation: profitability exists, though durability is less certain under stress.

Growth & Forward Outlook

Two key indicators frame the near-term view: TTM revenue growth of 0.53% indicating muted but still positive top-line momentum across the company, while the estimated 12-month price change of 61.04%, where consensus pricing assumptions suggest sizable appreciation potential. The near-term return case is built on whether reported trends and analyst projections can remain close enough to make current prices look justified. Whether the setup resolves positively or negatively will depend as much on the macro backdrop as on the capacity of the company to deliver against current estimates. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.

This summary is based on publicly available quantitative data and is not intended as investment advice. Carefully consider your personal financial circumstances before making any decisions.